@article{Verma_Chaudhary_Gupta_Saroj_2020, title={A comparative study of tapentadol versus tramadol in the treatment of low back pain}, volume={9}, url={https://www.ijbcp.com/index.php/ijbcp/article/view/4048}, DOI={10.18203/2319-2003.ijbcp20202942}, abstractNote={<p><strong>Background: </strong>Nontraumatic musculoskeletal disorders are the main reason for presentation to the emergency department with Rachialgia being the most common reason to request medical assessment among them. </p><p><strong>Methods:</strong> This was a prospective, randomized, parallel group open labelled study conducted in a district level tertiary care hospital attached to a medical teaching institute. Patients were randomized into two groups. Group I (63 patients) received tablet tramadol 50 mg twice daily orally and group II (63 patients) received tablet tapentadol 50 mg twice daily orally.</p><p><strong>Results:</strong> The mean age of the patients of group I was 40.6±9.6 years and in the group II was 42.7±10.6 years. A total of 61 males participated in the study of which 31 males were enrolled in group I and 30 in group II while 65 females participated in the study of which 32 females were enrolled in group I and 33 in group II. The mean reduction of pain intensity VAS score at the end of 4 weeks from baseline in group I and group II were 34.57 and 37.55 respectively. The difference in the mean reduction of pain intensity VAS between the two groups was not statistically significant.</p><p><strong>Conclusions:</strong> We conclude that both the drugs show significant reduction in the pain intensity in moderate to severe CLBP patients. Tapentadol is as efficacious as tramadol in moderate to severe CLBP. However, tapentadol is better tolerated than tramadol.</p>}, number={7}, journal={International Journal of Basic & Clinical Pharmacology}, author={Verma, Laxman and Chaudhary, Pankaj Kumar and Gupta, Chandresh and Saroj, Umesh}, year={2020}, month={Jun.}, pages={1064–1068} }